Mode
Text Size
Log in / Sign up
N/A N=129

Optical Coherence Tomography Angiography Evaluation of Ocular Changes in Patients With Carotid Artery Stenosis

Carotid Stenosis

Enrolled (actual)
129
Serious AEs
1.6%
Results posted
Oct 2020
Primary outcome: Primary: Radical Peripapillary Capillaries Vessel Density — 55.95; 57.24 percentage of vessel

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Carotid artery revascularization procedure (Procedure); Optical coherence tomography angiography (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
First Affiliated Hospital of Harbin Medical University
Primary completion
Jun 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Radical Peripapillary Capillaries Vessel Density
55.95; 57.24
PRIMARY
Superficial Vascular Complexes Vessel Density
48.65; 52.22
PRIMARY
Deep Vascular Complexes Vessel Density
49.65; 57.50
PRIMARY
Choriocapillaris Vessel Density
67.41; 68.74
SECONDARY
Change of Difference of Mean Transit Time(dMTT)
-0.22
SECONDARY
Change of the Ratio of Cerebral Blood Flow(rCBF)
0.19
SECONDARY
Changes of Retinal Nerve Fiber Layer
2.50
SECONDARY
Changes of Deep Vascular Complexes Vessel Density
4.00
SECONDARY
Changes of Radical Peripapillary Capillaries Vessel Density
1.55
SECONDARY
Changes of Superficial Vascular Complexes Vessel Density
1.70

Summary

This study aims to evaluate ocular changes in patients with carotid artery stenosis by optical coherence tomography angiography before and after carotid artery revascularization procedure.

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of carotid artery stenosis
  • Age-gender-race-matched controls

Exclusion Criteria

  • age 21 mmHg
  • VA >logMAR 1.0
  • spherical equivalent (SE) between >1.00 or < -6.00 D
  • other serious eye diseases which may affect OCTA results including diabetic retinopathy, hypertensive retinopathy, retinal vascular occlusion, age-related macular degeneration, and uveitis
  • major intraocular surgery performed in the past 6 months or a history of laser photocoagulation or intravitreal injection
  • glaucoma or first-degree relatives with a history of glaucoma; and
  • any disease that might cause poor scan quality (image quality <6).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04326842). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search